Holly Foot
Overview
Explore the profile of Holly Foot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hattingh L, Baysari M, Foot H, Sim T, Keijzers G, Morgan M, et al.
Trials
. 2024 Nov;
25(1):745.
PMID: 39516775
No abstract available.
2.
Moon Z, Kaplan A, Mak V, Nannini L, Winders T, Chan A, et al.
NPJ Prim Care Respir Med
. 2024 Nov;
34(1):36.
PMID: 39500901
Over-use of SABA is associated with poor asthma control and greater risk of exacerbations and death. Identifying and addressing the beliefs driving SABA over-reliance is key to reducing over-use. This...
3.
Hattingh L, Baysari M, Foot H, Sim T, Keijzers G, Morgan M, et al.
Trials
. 2024 Sep;
25(1):632.
PMID: 39334438
Background: General practitioners (GP) and community pharmacists need information about hospital discharge patients' medicines to continue their management in the community. This necessitates effective communication, collaboration, and reliable information-sharing. However,...
4.
Foot H, Chan A, Horne R
Front Pharmacol
. 2024 Jul;
15:1351851.
PMID: 39005938
Introduction: Despite anti-inflammatory reliever (AIR) therapy now being the preferred treatment choice across all severities of asthma, many patients are still "attached" to their short-acting beta-agonist (SABA) reliever, believing this...
5.
Almeshal N, Foot H, Clarke A, Chan A, Horne R
Front Pharmacol
. 2024 Jul;
15:1399698.
PMID: 38962318
Background: Reducing antimicrobial resistance (AMR) is a priority for public health. Inappropriate patient demand is an important driver of unnecessary antibiotic use. To develop an effective intervention to reduce inappropriate...
6.
Foot H, Beyene K, Horne R, Fingleton J, Harrison J, Chan A
Patient Prefer Adherence
. 2024 Feb;
18:361-371.
PMID: 38344153
Purpose: The aim of this study was to evaluate the feasibility of a community pharmacy-delivered intervention to shift patients' beliefs about short-acting beta agonists (SABA) in asthma management. The study...
7.
Martinez M, Lopez J, Molina J, Sorribas M, Arancon M, de Simon R, et al.
J Allergy Clin Immunol Glob
. 2023 Oct;
2(2):100077.
PMID: 37780788
Background: Patient beliefs about their asthma and its treatment may contribute to overreliance on short-acting β-agonist (SABA) therapy, leading to increased risk for potentially life-threatening exacerbations. The SABA Reliance Questionnaire...
8.
Costello J, Barras M, Foot H, Cottrell N
Explor Res Clin Soc Pharm
. 2023 Sep;
11:100305.
PMID: 37655116
Background: Clinical pharmacists have been shown to identify and resolve medication related problems post-discharge, however the impact on patient clinical outcomes is unclear. Aims: To undertake a systematic review to...
9.
Foot H, Kirkpatrick C, Russell G, Sturman N, Cossart A, Freeman C
Res Social Adm Pharm
. 2022 Oct;
19(3):510-516.
PMID: 36261303
Background: Pharmacist and general practitioner (GP) collaborative models of care are continuing to evolve in the Australian primary care setting. The REMAIN HOME study investigated whether a pharmacist integrated into...
10.
Chan A, Foot H, Pearce C, Horne R, Foster J, Harrison J
PLoS One
. 2022 Mar;
17(3):e0265715.
PMID: 35312704
Introduction: Electronic adherence monitoring (EAM) is increasingly used to improve adherence. However, there is limited evidence on the effect of EAM in across chronic conditions and on patient acceptability. We...